期刊文献+

阿糖胞苷对肺腺癌细胞凋亡的诱导作用及其机制 被引量:2

STUDY ON MECHANISM OF APOPTOSIS OF LUNG ADENOCARCINOMA CELL INDUCED BY CYTARABINE
下载PDF
导出
摘要 目的探讨阿糖胞苷(Ara-C)对人肺腺癌细胞株A549的凋亡诱导作用及其机制。方法Ara-C体外作用于A549细胞,噻唑蓝还原法(MTT法)检测Ara-C对A549细胞增殖的抑制作用;Hoechst33258荧光染色观察细胞核形态学的变化;单细胞凝胶电泳技术(comet assay)测定A549细胞DNA的损伤程度;以Western blotting进一步证明A549细胞发生凋亡。结果Ara-C对A549细胞的增殖有明显抑制作用;观察到特异性的凋亡小体;Ara-C导致A549细胞发生DNA链断裂,并呈明显剂量依赖性增强:Western blotting显示caspase 8,9,3都不同程度被激活,多聚ADP核糖聚合酶(PARP)被剪切降解。结论揭示了Ara-C明显诱导A549细胞凋亡;细胞凋亡通路不仅通过线粒体途径,还通过膜受体途径,两条通路协同作用使凋亡信号增强;提示Ara-C对A549细胞有明显的化疗作用。 Objective To study the mechanism of apoptosis of human lung adenocarcinoma cell line A549 induced by cytarabine (Ara-C) in vitro. Methods Ara-C induced dose-dependent inhibition of cell proliferation by MTr assay. Morphological changes of the A549 cells stained with Hoechst33258 were observed by microscopy; The DNA fragments were detected by single-cell gel electrophoresis ( comet assay) ; The expressions of caspase3,8,9, and poly (ADP-ribose) polymerase (PARP) apoptosis-related protein were investigated by Western blotting. Results After a 72 hours exposure to Ara-C, A549 cells were detected by classic apoptotic morphology, DNA fragmentation, activation of caspase 3, and PARP degradation. Ara-C induced DNA damage was associated with activation of caspase 9, a mitochondrial-activated caspase. In contrast, a lower level of caspase 8, the death receptor-activated caspase, was detected in Ara-C-exposed A549.Conelusion Ara-C can effectively induce apoptosis of human lung adenocarcinoma cell llne A549 and simultaneously Ara-C-induced apoptosis is mediated mainly through a mitochondrion-dependent pathway and partly through a receptor-dependent pathway.
出处 《解剖学报》 CAS CSCD 北大核心 2006年第4期431-435,共5页 Acta Anatomica Sinica
关键词 阿糖胞苷 细胞凋亡 单细胞凝胶电泳技术 噻唑蓝还原法 WESTERN BLOTTING A549细胞 Cytarabine Apoptosis Comet assay MTrassay Western blotting A549 cells
  • 相关文献

参考文献14

  • 1Rapp E PJ,Willan A,Cormier Y,et al.Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial[J].Journal Clinical Oncology,1988,16(4):633-641.
  • 2Grilli R OA,Julian JA.Chemotherapy for advanced non-small-cell lung cancer:how much benefit is enough[J] ? J Clin Oncol,1993:11 (10):1866-1872.
  • 3Kufe DW GJ,Spriggs DR.Cellular and clinical pharmacology of lowdose Ara-C[J].Semin Oncol,1985,12 (2):200-207.
  • 4Gandhi WPaV.Cellular pharmacodynamics of anticancer druges[J].Semin Oncol,1993,20(1):50-63.
  • 5Markman M HT,Reichman B,Hoskins W,et al.Intraperitoneal cytosine arabinoside therapy in ovarian carcinoma[J].J Clin Oncol,1999,9(2):204-210.
  • 6Wang LM WJ,Capizzi RL.The effect of Ara-C-induced inhibition of DNA synthesis on its cellular pharmacology[J].Cancer Chemother Pharmacol,1990,25(6):418-424.
  • 7Tommer Ravid RA,Sylvie PC,Jerry R,et al.Impaired regulation of 3 hydroxy-3-methylglutary1 -coenzyme a reductase degradation in lovastatin-resistant cells[J].J Biol Chem,1999,274 (41):29341-29351.
  • 8Syu-ichi Kanno,AH,Yurie W,et al.Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines[J].Toxicology Letters,2004,152(2):149-158.
  • 9Kroemer KFFG.Organelle-specific initiation of cell death pathways[J].Nat Cell Biol,2001,3 (11):E255-263.
  • 10Strasser A OCL,Dixit VM.Apoptosis signaling[J].Annu Rev Biochem,2000,69 (1):217-245.

同被引文献46

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部